Table 2.
Phytochemicals/plant foods | Mechanism of intervention | Type of BC research | References |
---|---|---|---|
EGCG | Alteration of histone acetylation and methylation status, ERα reactivation | MDA-MB-231 cells | [61] |
EGCG | Inhibition of HATs activities, hTERT promoter hypomethylation and histone deacetylations (acetyl-H3, acetyl-H3K9, and acetyl-H4) | MCF-7, MDA-MB-231 cells | [62] |
Curcumin and garcinol, | Reduction in H3K18ac (garcinol), elevated global levels of H4K16ac and H4K20m3 (garcinol), increased global levels of H3K18ac and H4K16ac (curcumin) | MCF-7 cells | [64] |
3,4′-dimethoxy-3′,5,7-trihydroxyflavone from Myoporum bontioides L. | Downregulation of HDAC2 and HDAC4 expression, increase of H3ac | MCF-7 cells | [50] |
Secoiridoids | Histone hyperacetylation | JIMT-1 cells | [65] |
Diallyl disulphide/garlic oil | HDAC inhibition | MCF-7 cells | [66] |
Luteolin (flavonoid) | HDAC inhibition | MCF-7/6 and MDA-MB231–1833 cells | [68] |
Triterpenoid 5β,19-epoxy-19-methoxycucurbita-6,23-dien-3β,25-diol from Momordica charantia L. | Downregulation of HDAC1, increase in H3ac | MCF-7 | [69] |
Soy phytoestrogens (isoflavones) | Histones demethylation and acetylation (H3K27me3, H3K9me3, H3K4me3, H4K8ac, and H3K4ac) | MCF-7 and MDA-MB 231 cells | [75] |
Genistein | Histones modification in theERα promoter, reactivation of ERα expression | Mouse BC model using MDA-MB-231 cells | [74] |
Genistein | Histone modifications in the promoters of p21 and p16 genes | HMECs, SH, SHR, MDA-MB-231 | [76] |
Clove buds (mixture of phenolic acids, flavonol glucosides, tannins and phenolic volatile oils – eugenol, acetyl eugenol) | Increase in lysine trimethylations and acetylations (H4K20me3, H4K16ac) | Rat BC model | [40] |
Extra virgin olive oil | Decrease in H4K20m3 levels in mammary tumors or glands | Rat BC model | [39] |
EGCG, epigallocatechin gallate; ER, estrogen receptor; HDAC, histone deacetylase; HAT, histone acetyltransferase